Side-by-side comparison of AI visibility scores, market position, and capabilities
Arlington VA aerospace and defense conglomerate (NYSE: RTX) at $80.7B 2024 sales (+9%) with $218B backlog; Collins Aerospace/Pratt & Whitney/Raytheon segments and 2025 guidance of $83-84B competing with Lockheed Martin.
RTX Corporation is an Arlington, Virginia-based global aerospace and defense technology company — publicly traded on the New York Stock Exchange (NYSE: RTX) as an S&P 500 and Dow Jones Industrial Average component — operating as the world's second-largest aerospace and defense company by sales through three business segments: Collins Aerospace (avionics, aerostructures, and aerospace systems), Pratt & Whitney (commercial and military jet engines), and Raytheon (defense systems including missiles, air defense, and cybersecurity). RTX was formed through the April 2020 merger of United Technologies Corporation (founded 1929) and Raytheon Company (founded 1922), and renamed from Raytheon Technologies to RTX in July 2023. In fiscal year 2024, RTX reported sales of $80.7 billion (+9% year-over-year), adjusted EPS of $5.73 (+13%), and free cash flow of $6.6 billion. RTX provided 2025 guidance of $83-84 billion in sales and $6.00-$6.15 adjusted EPS, reflecting 4-6% organic growth. The company employs approximately 185,000 people worldwide and maintains a combined $218 billion backlog ($125 billion commercial, $93 billion defense).
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.